Jubilant Pharmova gets nod to sell, transfer API business to Jubilant Biosys

13 Jun 2025 Evaluate

Jubilant Pharmova has received approval for sale and transfer of the active pharmaceutical ingredients (API) business of the company on a slump sale basis to Jubilant Biosys (JBL), a wholly-owned subsidiary company, engaged in providing drug discovery services to global Pharmaceutical and Biotech companies.

The board of directors of the company in their meeting held on June 12, 2025 has approved the same.

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.

Jubilant Pharmova Share Price

1055.90 -18.85 (-1.75%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×